聚合搜Scholar - 壹搜网为您找到"

科技爱好者周刊(第 390 期):没有语料,大模型就是智障

"相关结果 10条

AMBER Trial (Amla-Based Extract for Endobronchial Ultrasound Cough Reduction): A Randomized Controlled Study.

Cough during endobronchial ultrasound (EBUS) is common and can reduce patient comfort, prolong procedures, and compromise diagnostic yield. While dextromethorphan has demonstrated antitussive efficacy, concerns remain regarding side effects and availability. Emblica officinalis (Amla) is a traditional herbal medicine with reported antitussive properties, but human evidence is lacking.
www.ncbi.nlm.nih.gov

Low colorectal cancer screening among adults aged 45-49 years in the US, 2023.

Colorectal cancer (CRC) screening has been recommended for US adults aged 45 to 49 years. This study examined the rate and predictors of CRC screening in 2023 among adults aged 45 to 49 years vs adults aged 50 to 54 years.
www.ncbi.nlm.nih.gov

Coordinated psycho-oncology in young adults with breast cancer: equity gradients, timely access, and out-of-pocket spending in China.

Young women undergoing radical mastectomy in China have substantial psychosocial needs, yet equity of access to coordinated psycho-oncology care remains uncertain.
www.ncbi.nlm.nih.gov

科技期刊与新型智库建设

www.xiahepublishing.com

Health-related Quality of Life with Encorafenib plus Binimetinib for BRAFV600E Thyroid Cancer.

A Japanese phase 2 trial of encorafenib plus binimetinib met the primary endpoint of the centrally assessed objective response rate in patients with unresectable BRAF V600-mutated thyroid cancer. Consequently, encorafenib plus binimetinib has been approved in Japan. We present the health-related quality of life (HR-QoL) outcomes from the trial.
www.ncbi.nlm.nih.gov

Development and analysis of a nomogram for predicting pathological response to neoadjuvant immunochemotherapy in locally advanced gastric cancer.

Neoadjuvant immunochemotherapy (NICT) has demonstrated potential to enhance tumor regression in patients with locally advanced gastric cancer (LAGC). However, the benefits for some patients are limited. Existing biological markers have only restricted ability to predict pathological response. New biomarkers and predictive models are essential for identifying patients optimally responsive to immunotherapy.
www.ncbi.nlm.nih.gov

A decade of change: trends in drug and alcohol use in Iran (2010-2019).

Drug and alcohol use poses critical public health challenges. This study estimated the prevalence of drug and alcohol use in Iran for 2019 and assessed its trends over the last decade, comparing 2019 data with our previous estimates in 2013 and 2016.
www.ncbi.nlm.nih.gov